Analgesic Efficacy of Ropivacaine Infiltration on Early Post‐Tonsillectomy Pain in Pediatrics
The Laryngoscope · 2024-07 · 134 (7) · 3018-3029
DOI: 10.1002/lary.31292 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Laryngoscope, online erschienen am 18.01.2024. Verfasst von Ebraheem Albazee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Kuwait Institute for Medical Specializations (KIMS), Kuwait City, Kuwait. Hauptthemen laut MEDLINE: Postoperative Pain, Tonsillectomy, Ropivacaine, Anesthetics, Local. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Objective
To assess the analgesic efficacy of ropivacaine infiltration in the tonsillar fossa among pediatric patients undergoing tonsillectomy. Data Sources PubMed, Scopus, Web of Science, and CENTRAL. Review Methods Eligible randomized controlled trials (RCTs) were assessed for bias using Cochrane's risk of bias tool (version 2). Our primary outcome was postoperative pain within 24 h, and secondary outcomes included operative time, intraoperative blood loss, time to first analgesia, bleeding, and nausea/vomiting. Data were pooled as mean difference, standardized mean difference, and risk ratio with a 95% confidence interval.
Results
Our review included 11 RCTs, with a total of 712 patients. The quality of studies varied and included low risk ( n = 8 RCTs), some concerns ( n = 2 RCTs), and high risk ( n = 1 RCT) of bias. The primary endpoint of postoperative pain across all time points was significantly reduced in the ropivacaine group compared with the placebo group. Trial sequential analysis (TSA) of the postoperative pain depicted conclusive evidence and unnecessity for further RCTs. The mean operative time was significantly reduced in the ropivacaine group compared with the placebo group. However, there was no significant difference between both groups regarding additional clinical (i.e., mean intraoperative blood loss and mean time to first analgesia) and safety (i.e., rates of bleeding and nausea/vomiting) outcomes.
Conclusion
This systematic review and meta‐analysis demonstrated the safety and postoperative analgesic efficacy of ropivacaine versus placebo among pediatric patients undergoing tonsillectomy. There was no significant difference between both groups regarding intraoperative blood loss, time to first analgesia, and rate of postoperative bleeding. Level of Evidence 1 Laryngoscope , 134:3018–3029, 2024
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Kuwait Institute for Medical Specializations (KIMS), Kuwait City, Kuwait.
- Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
- School of Public Health, The University of Memphis, Memphis, Tennessee, U.S.A.
- College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
ORCID-Profile: Ebraheem Albazee, Omar A Abdelwahab, Ahmed Abdelaziz, Ahmed Abu-Zaid
Zitieren
APA
Albazee, E., Abdelwahab, O. A., Abdelaziz, A., Magzoub, D., & Abu-Zaid, A. (2024). Analgesic Efficacy of Ropivacaine Infiltration on Early Post‐Tonsillectomy Pain in Pediatrics. The Laryngoscope, 134(7), 3018-3029. https://doi.org/10.1002/lary.31292
Vancouver
Albazee E, Abdelwahab OA, Abdelaziz A, Magzoub D, Abu-Zaid A. Analgesic Efficacy of Ropivacaine Infiltration on Early Post‐Tonsillectomy Pain in Pediatrics. The Laryngoscope. 2024;134(7):3018-3029. doi:10.1002/lary.31292
BibTeX
@article{Albazee2024,
author = {Albazee, Ebraheem and Abdelwahab, Omar A and Abdelaziz, Ahmed and Magzoub, Duha and Abu-Zaid, Ahmed},
title = {Analgesic Efficacy of Ropivacaine Infiltration on Early Post‐Tonsillectomy Pain in Pediatrics},
journal = {The Laryngoscope},
year = {2024},
volume = {134},
number = {7},
pages = {3018--3029},
doi = {10.1002/lary.31292}
}
EUVIMED